Artificial Intelligence is changing software development forever. In 2026, companies are not only hiring traditional software developers. They are looking for AI Software Developers who can build ...

Implementation sits outside Part D, with Humana handling PA, adjudication, and reimbursement; manufacturers provide a $245 net price for Wegovy, Zepbound, and orforglipron. Eligibility requires PA and ...

An expert explains how the new program, which launches July 1, will work and who is eligible Key Takeaways A new Medicare pilot program will offer GLP-1 weight-loss medications for $50 a month ...

CLEVELAND, Ohio — Eligible Americans on Medicare may be able to get a month’s supply of some GLP-1 drugs for $50 from July 1 through the end of the year, the Centers for Medicare & Medicaid Services ...

More access to affordable weight-loss medications is coming this summer for adults on Medicare. Starting in July, certain Medicare enrollees can pay $50 a month for specific prescription GLP1 ...

The initiative is part of the administration’s focus on addressing technology and cybersecurity vacancies by placing an emphasis on skill-based hiring. The Department of Defense is launching a Cyber ...

S15 - E19 Reunion Part 1 The reunion kicks off with some of the ladies seeking resolution while others remain doubtful following an emotionally charged season. A red-carpet sighting sparks questions ...

WASHINGTON, April 23 (Reuters) - The Trump administration has approved only one Gold Card visa under a program granting U.S. residency to non-citizens for a $1 million fee, ‌Commerce Secretary Howard ...

Medicare has delayed a program for older Americans that would've required participating insurance companies to cover GLP-1 weight loss drugs such as Novo Nordisk's Wegovy and Eli Lilly's Zepbound.

Customers will be able to compare insurance and cash-pay prices at checkout, with manufacturer coupons automatically applied to those eligible. (iStock / Getty Images Plus) Amazon One Medical has ...

The bridge program operates outside of the Part D plan's usual payment flow, so insurers do not have to opt in and will not carry risk for drugs furnished under the model, CMS said on its website.

Amazon.com AMZN-1.23%decrease; down pointing triangle is launching a program that provides access to GLP-1 treatments through its One Medical primary care arm. The company said Tuesday the new program ...